Biotechnology VALUE FUND II L.P., 10% Owner at Merus N.V. (MRUS), bought 167,924 shares at $14.98 ($2.5M) on 2020-01-13, disclosed to the SEC on 2020-01-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.98 | 5,406 | $81K | 3.2% |
| 2 | $14.98 | 5,406 | $81K | 3.2% |
| 3 | $14.98 | 25,108 | $376K | 15.0% |
| 4 | $14.98 | 25,108 | $376K | 15.0% |
| 5 | $14.98 | 53,448 | $801K | 31.8% |
| 6 | $14.98 | 53,448 |
| $801K |
| 31.8% |
| Total | $14.98 avg | 167,924 | $2.5M | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |